# A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects

> **NCT01474941** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-04620110 or Placebo
- **DRUG:** PF-04620110 or Placebo
- **DRUG:** PF-04620110 or Placebo

## Key facts

- **NCT ID:** NCT01474941
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2012-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01474941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01474941, "A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01474941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*